New Results

The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

Markus Hoffmann, Hannah Kleine-Weber, Nadine Krüger, Marcel Müller, Christian Drosten, Stefan Pöhlmann
doi: https://doi.org/10.1101/2020.01.31.929042

Article usage

Article usage: February 2020 to March 2025

AbstractFullPdf
Feb 202016176315112988
Mar 202020857525912576
Apr 2020908221525622
May 2020512210873028
Jun 202024385341317
Jul 20202041347863
Aug 20201347236749
Sep 20201308293647
Oct 20201240366712
Nov 20201169210545
Dec 20201035223444
Jan 20211320182484
Feb 20211018102295
Mar 20211234144340
Apr 20211147213338
May 20211079154346
Jun 2021819119273
Jul 202199688232
Aug 202193883199
Sep 2021763109208
Oct 202163578218
Nov 202154888184
Dec 202147081140
Jan 2022584119178
Feb 202258413997
Mar 2022459180144
Apr 2022510126160
May 2022473125200
Jun 2022540130145
Jul 20224537995
Aug 20225237596
Sep 202261586105
Oct 20224085595
Nov 202241244111
Dec 20225427191
Jan 20233865291
Feb 20233124294
Mar 20234996885
Apr 20233595373
May 20232954188
Jun 20233134763
Jul 20232834237
Aug 20232993667
Sep 20233797771
Oct 20232838263
Nov 20233037452
Dec 20233884768
Jan 202432135996
Feb 2024243261564
Mar 202430052264
Apr 20242819494
May 20242191666
Jun 202435814958
Jul 20242082080
Aug 202417421151
Sep 202420118102
Oct 20242341664
Nov 20242373180
Dec 20242292786
Jan 20251491747
Feb 20252553859
Mar 202593910
Back to top
Posted January 31, 2020.
Download PDF
Email
The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells
Markus Hoffmann, Hannah Kleine-Weber, Nadine Krüger, Marcel Müller, Christian Drosten, Stefan Pöhlmann
bioRxiv 2020.01.31.929042; doi: https://doi.org/10.1101/2020.01.31.929042
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area